Bimal R. Shah - 06 Oct 2023 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Director
Signature
/s/ Bimal Shah
Issuer symbol
ANEB
Transactions as of
06 Oct 2023
Net transactions value
$0
Form type
4
Filing time
10 Oct 2023, 21:49:29 UTC
Next filing
17 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Stock Option (right to buy) Award $0 +26,097 $0.000000 26,097 06 Oct 2023 Common Stock 26,097 $3.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the original number of shares vest on the first anniversary of October 6, 2023 (the "Vesting Commencement Date") and 2.0833% of the original number of shares vest at the end of each successive month following the first anniversary of the Vesting Commencement Date until the fourth anniversary of the Vesting Commencement Date.